TITLE

Omega-3 Fatty Acids for Cardioprotection

AUTHOR(S)
Lee, John H.; O'Keefe, James H.; Lavie, Carl J.; Marchioli, Roberto; Harris, William S.
PUB. DATE
March 2008
SOURCE
Mayo Clinic Proceedings;Mar2008, Vol. 83 Issue 3, p324
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The most compelling evidence for the cardiovascular benefit provided by omega-3 fatty acids comes from 3 large controlled trials of 32,000 participants randomized to receive omega-3 fatty acid supplements containing docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) or to act as controls. These trials showed reductions in cardiovascular events of 19% to 45%. These findings suggest that intake of omega-3 fatty acids, whether from dietary sources or fish oil supplements, should be increased, especially in those with or at risk for coronary artery disease. Patients should consume both DHA and EPA. The target DHA and EPA consumption levels are about 1 g/d for those with known coronary artery disease and at least 500 mg/d for those without disease. Patients with hypertriglyceridemia benefit from treatment with 3 to 4 g/d of DHA and EPA, a dosage that lowers triglyceride levels by 20% to 50%. Although 2 meals of oily fish per week can provide 400 to 500 mg/d of DHA and EPA, secondary prevention patients and those with hypertriglyceridemia must use fish oil supplements if they are to reach 1 g/d and 3 to 4 g/d of DHA and EPA, respectively. Combination therapy with omega-3 fatty acids and a statin is a safe and effective way to improve lipid levels and cardiovascular prognosis beyond the benefits provided by statin therapy alone. Blood DHA and EPA levels could one day be used to identify patients with deficient levels and to individualize therapeutic recommendations.
ACCESSION #
31154405

 

Related Articles

  • Coronary Heart Disease: How Do the Benefits of ω-3 Fatty Acids Compare with Those of Aspirin, Alcohol/Red Wine, and Statin Drugs? Basu, Hemendra; Pernecky, Steve; Sengupta, Aditi; Liepa, George U. // Journal of the American Oil Chemists' Society (JAOCS);Dec2006, Vol. 83 Issue 12, p985 

    At the present time the primary cause of death of most Americans is cardiovascular disease. Approximately 20 million Americans are currently being treated with some form of statin drugs as a means to lower their blood cholesterol levels, and many of these same people also consume some...

  • DHA: improving life during all lifestages. Kurstjens, John // Wellness Foods Europe;May2010, Issue 1, p34 

    The article explains the importance of docosahexaenoic acid (DHA), the omega-3 fatty acid which benefits the vital developmental roles and in maintaining the normal functions of the retina in vision and the brain and nervous system. The roles of DHA in the formation of human brain tissue,...

  • Study Says Benefits of Eating Fish Outweigh Risks. Dye, Dayna // Life Extension;Jan2007, Vol. 13 Issue 1, p14 

    The article reports on the findings of the study regarding the effects of regular consumption of fish on human health in the U.S. The study suggests that regular eating of fish reduces the risk of developing coronary heart disease because of the omega-3 fatty acids and docosahexaenoic acids...

  • How Much Fish Oil Is in Your Blood? Faloon, William // Life Extension;2008 Collector's Edition, Vol. 14, p36 

    The article discusses the ability of the two active ingredients of omega-3 fish oil, which are the eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in defending against coronary artery disease. According to a study, the risk of unstable heart attack was reduced by an astounding 62%...

  • Healthy Fats: No Longer an Oxymoron. Berry, Donna // Dairy Foods;Dec2004, Vol. 105 Issue 12, p41 

    Focuses on the healthy facts of omega-3 fatty acids. Availability of a qualified health claim linking consumption of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA); Reduction of the risk of coronary heart disease brought by the consumption of EPA and DHA...

  • Super EPA/DHA with Sesame Lignans.  // Life Extension;Winter2004/2005, p43 

    The article reports that supportive but not conclusive research shows that the consumption of EPA and DHA omega-3 fatty acids may reduce the risk of coronary heart disease. The new supplement Super EPA/DHA with Sesame Lignans softgel capsule provides 350 mg of EPA, 250 mg of DHA, and 10 mg of...

  • Omega-3 index levels and associated factors in a middle-aged French population: the MONA LISA-NUT Study. Wagner, A; Simon, C; Morio, B; Dallongeville, J; Ruidavets, J B; Haas, B; Laillet, B; Cottel, D; Ferrières, J; Arveiler, D // European Journal of Clinical Nutrition;Apr2015, Vol. 69 Issue 4, p436 

    Background/Objectives:The omega-3 index (the summed percentage content of eicosapentaenoic and docosahexaenoic acids in red blood cells) is associated with a lower risk of fatal coronary heart disease and sudden cardiac death. We aimed to determine which socio-demographic, behavioural or...

  • Association of Marine Omega-3 Fatty Acid Levels With. Rigatti, Steven J. // Journal of Insurance Medicine;2010, Vol. 42 Issue 1, p44 

    The article discusses research being done on the relationship between marine omega-3 fatty acid levels and telomeric aging in individuals suffering from coronary heart disease. It references a study by E. S. Epel and colleagues in a 2010 issue of the "Journal of the American Medical...

  • Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial. Dunbar, Richard L.; Nicholls, Stephen J.; Maki, Kevin C.; Roth, Eli M.; Orloff, David G.; Curcio, Danielle; Johnson, Judith; Kling, Douglas; Davidson, Michael H. // Lipids in Health & Disease;9/2/2015, Vol. 14 Issue 1, p1 

    Background: This study examined the effects of a mixture of highly bioavailable omega-3 carboxylic acids (OM3-CA) on nuclear magnetic resonance spectroscopy-assessed lipoprotein particle concentrations and sizes and other cardiovascular risk markers in statin-treated patients with fasting...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics